Allyl-succinylated collagen

1 paper4 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Funder: National Natural Science Foundation of China

Animals1

Outcomes

Ki67

upin animals1

1 study

Allyl-succinylated collagen increases Ki67.
“upregulation of regenerative markers, such as Ki67 and EGF”
Animalsin a full-thickness diabetic wound model
Photocurable Allyl-Succinylated Collagen Bioink for High-Resolution 3D Bioprinting and Regenerative Diabetic Wound Healing
ACS biomaterials science & engineering17 Aug 2026

Latest

1 in 12 months

ACS Biomaterials Science & Engineering17 Aug

Photocurable Allyl-Succinylated Collagen Bioink for High-Resolution 3D Bioprinting and Regenerative Diabetic Wound Healing

Experiments in animalsSkin

Paper

Allyl-succinylated collagen

Outcomes

Latest

Photocurable Allyl-Succinylated Collagen Bioink for High-Resolution 3D Bioprinting and Regenerative Diabetic Wound Healing

Related